Reply to “Interpreting cardiovascular morbidity after acromegaly diagnosis”
European Journal of Endocrinology · 14.11.2026
DOI: 10.1093/ejendo/lvag201 ↗Kurz gefasst
Fachartikel in der Zeitschrift European Journal of Endocrinology, online erschienen am 14.11.2026. Verfasst von Antti Partanen und 4 weiteren Autor:innen. Beteiligte Einrichtung: Tampere University, Faculty of Medicine and Health Technology, Tampere, Finland.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Tampere University, Faculty of Medicine and Health Technology, Tampere, Finland.
- Tampere University Hospital, Department of Internal Medicine, Wellbeing Services County of Pirkanmaa, Tampere, Finland.
- Fimlab laboratories, Department of Clinical Chemistry, Wellbeing Services County of Pirkanmaa, Tampere, Finland.
- Tampere University, Faculty of Social Sciences.
- Endocrinology, Abdominal Center, Helsinki University Hospital and University of Helsinki, ENDO-ERN (European Reference Network on Rare Endocrine Conditions), Helsinki, Finland.
ORCID-Profile: Antti Partanen, Camilla Schalin-Jäntti
Zitieren
APA
Partanen, A., Peltola, E., Huhtala, H., Schalin-Jäntti, C., & Jaatinen, P. (2026). Reply to “Interpreting cardiovascular morbidity after acromegaly diagnosis”. European Journal of Endocrinology. https://doi.org/10.1093/ejendo/lvag201
Vancouver
Partanen A, Peltola E, Huhtala H, Schalin-Jäntti C, Jaatinen P. Reply to “Interpreting cardiovascular morbidity after acromegaly diagnosis”. European Journal of Endocrinology. 2026. doi:10.1093/ejendo/lvag201
BibTeX
@article{Partanen2026,
author = {Partanen, Antti and Peltola, Elina and Huhtala, Heini and Schalin-Jäntti, Camilla and Jaatinen, Pia},
title = {Reply to “Interpreting cardiovascular morbidity after acromegaly diagnosis”},
journal = {European Journal of Endocrinology},
year = {2026},
doi = {10.1093/ejendo/lvag201}
}
EUVIMED